Data from: Effectiveness of ritonavir-boosted protease inhibitor monotherapy in clinical practice even with previous virological failures to protease inhibitor-based regimens

Patricia Jiménez-Aguilar, Juan Pasquau-Liaño, Pompeyo Viciana, Luis López-Cortés, Miguel López-Ruz, Zaira Palacios-Baena, Dolores Merino Merino, José Fajardo-Pico, José Hernández-Quero, Alberto Terrón-Pernía, Guillermo Ojeda-Burgos, Manuel Marquez-Solero, David Vinuesa-Garcia, Manuel A. Castaño Castaño, María Rios-Villegas, Alberto Romero-Palacios, Francisco Tellez-Pérez, Francisco Orihuela-Cañadas Orihuela-Cañadas, Miguel A. López-Ruz & María J. Rios-Villegas
Background and objective: Significant controversy still exists about ritonavir-boosted protease inhibitor monotherapy (mtPI/rtv) as a simplification strategy that is used up to now to treat patients that have not experienced previous virological failure (VF) while on protease inhibitor (PI)-based regimens. We have evaluated the effectiveness of two mtPI/rtv regimens in an actual clinical practice setting, including patients that had experienced previous VF with PI-based regimens. Methods: This retrospective study analyzed 1060 HIV-infected patients with undetectable...

Registration Year

  • 2016
    1

Resource Types

  • Dataset
    1

Affiliations

  • Hospital Universitario Virgen Macarena
    1
  • Hospital Universitario Virgen de las Nieves
    1
  • Institute of Biomedicine of Seville
    1
  • Hospital Universitario Puerto Real
    1
  • Hospital Clínico Universitario Virgen de la Victoria
    1